HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate Total Proof UK Ad Gets Broadcasters' Help In Regulator’s Review

This article was originally published in The Rose Sheet

Executive Summary

A Colgate Total Proof toothpaste UK TV ad did not falsely imply that an animated color change of the toothpaste is an indication of antibacterial capability but is an indicator of time spent brushing teeth, says the country's advertising regulator.

You may also be interested in...



Colgate Sensitivity Toothpaste Misses Instant Repair Mark In UK Ad Review

Colgate Sensitive Repair and Prevent toothpaste can relieve tooth sensitivity but cannot regenerate enamel that had worn away or restore receding gums, as suggested in a TV ad for the product, says UK Advertising Standards Authority.

North America Anchors Colgate As Currency Headwinds Continue Abroad

Innovation across categories helped make Colgate's North American business its star segment in the second quarter, rising 1.6% to $793m on strong oral care sales, while the firm’s international business remains impacted negatively by currency headwinds.

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121087

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel